NPORT-EX 3 efh_thealgerinstitutional.htm SOI

 

 

 

THE ALGER INSTITUTIONAL FUNDS

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—100.0%   SHARES     VALUE  
ADVERTISING—0.9%            
The Trade Desk, Inc., Cl. A*     214,103     $ 19,539,040  
AEROSPACE & DEFENSE—2.9%            
HEICO Corp.     99,930       17,585,681  
TransDigm Group, Inc.     50,541       45,472,749  
              63,058,430  
AGRICULTURAL & FARM MACHINERY—0.4%            
Deere & Co.     19,515       8,383,644  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%            
LVMH Moet Hennessy Louis Vuitton SE     11,894       11,046,766  
APPLICATION SOFTWARE—4.3%            
Adobe, Inc.*     56,851       31,050,311  
Cadence Design Systems, Inc.*     64,628       15,123,598  
Datadog, Inc., Cl. A*     143,962       16,803,245  
Intuit, Inc.     37,785       19,334,584  
Salesforce, Inc.*     45,919       10,332,234  
              92,643,972  
AUTOMOBILE MANUFACTURERS—1.7%            
Tesla, Inc.*     135,043       36,114,549  
AUTOMOTIVE PARTS & EQUIPMENT—0.4%            
Mobileye Global, Inc., Cl. A*     223,725       8,541,820  
BIOTECHNOLOGY—2.6%            
Natera, Inc.*     541,535       24,488,213  
Vaxcyte, Inc.*     412,593       19,829,219  
Vertex Pharmaceuticals, Inc.*     32,961       11,613,479  
              55,930,911  
BROADLINE RETAIL—8.1%            
Amazon.com, Inc.*     1,018,236       136,117,789  
MercadoLibre, Inc.*     31,041       38,430,310  
              174,548,099  
CARGO GROUND TRANSPORTATION—0.3%            
Old Dominion Freight Line, Inc.     17,803       7,468,180  
CASINOS & GAMING—3.7%            
DraftKings, Inc., Cl. A*     516,986       16,429,815  
Flutter Entertainment PLC*     120,028       23,873,514  
Las Vegas Sands Corp.*     387,584       23,181,399  
MGM Resorts International     315,848       16,035,603  
              79,520,331  
CONSTRUCTION & ENGINEERING—0.4%            
Quanta Services, Inc.     39,826       8,029,718  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—0.5%              
Wabtec Corp.     91,275       10,810,611  
CONSTRUCTION MATERIALS—1.4%            
Martin Marietta Materials, Inc.     67,225       30,013,273  
DIVERSIFIED BANKS—1.1%            
JPMorgan Chase & Co.     142,926       22,576,591  
ELECTRICAL COMPONENTS & EQUIPMENT—0.4%            
Eaton Corp. PLC     44,249       9,085,205  

 

- 2 - 

THE ALGER INSTITUTIONAL FUNDS

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—100.0% (CONT.)   SHARES     VALUE  
ENVIRONMENTAL & FACILITIES SERVICES—1.1%            
GFL Environmental, Inc.     681,704     $ 23,273,375  
FINANCIAL EXCHANGES & DATA—2.1%            
CME Group, Inc., Cl. A     62,704       12,475,588  
S&P Global, Inc.     79,866       31,507,935  
              43,983,523  
HEALTHCARE DISTRIBUTORS—0.9%            
McKesson Corp.     46,496       18,709,990  
HEALTHCARE EQUIPMENT—3.1%            
Boston Scientific Corp.*     439,489       22,787,505  
Dexcom, Inc.*     111,485       13,886,571  
GE HealthCare Technologies, Inc.     119,034       9,284,652  
Intuitive Surgical, Inc.*     65,178       21,143,743  
              67,102,471  
HEALTHCARE FACILITIES—0.8%            
Acadia Healthcare Co., Inc.*     213,022       16,835,129  
HOTELS RESORTS & CRUISE LINES—1.7%            
Booking Holdings, Inc.*     3,976       11,811,901  
Trip.com Group Ltd.#,*     593,113       24,341,357  
              36,153,258  
INDUSTRIAL GASES—0.5%            
Air Products & Chemicals, Inc.     36,240       11,065,159  
INTERACTIVE MEDIA & SERVICES—9.3%            
Alphabet, Inc., Cl. C*     718,171       95,595,742  
Meta Platforms, Inc., Cl. A*     306,118       97,529,195  
Pinterest, Inc., Cl. A*     194,908       5,650,383  
              198,775,320  
INTERNET SERVICES & INFRASTRUCTURE—0.4%            
MongoDB, Inc., Cl. A*     21,912       9,277,541  
LIFE SCIENCES TOOLS & SERVICES—1.1%            
Danaher Corp.     92,589       23,615,750  
MANAGED HEALTHCARE—1.2%            
UnitedHealth Group, Inc.     52,593       26,631,517  
MOVIES & ENTERTAINMENT—2.3%            
Liberty Media Corp. Series C Liberty Formula One*     179,591       13,038,307  
Netflix, Inc.*     80,569       35,367,374  
              48,405,681  
OIL & GAS EQUIPMENT & SERVICES—1.1%            
Schlumberger NV     386,135       22,527,116  
OIL & GAS EXPLORATION & PRODUCTION—2.0%            
Diamondback Energy, Inc.     101,559       14,961,672  
Hess Corp.     87,095       13,214,924  
Pioneer Natural Resources Co.     66,461       14,998,254  
              43,174,850  
OIL & GAS STORAGE & TRANSPORTATION—0.5%            
Cheniere Energy, Inc.     68,938       11,158,305  
PASSENGER GROUND TRANSPORTATION—0.5%            
Uber Technologies, Inc.*     235,867       11,665,982  

 

- 3 - 

THE ALGER INSTITUTIONAL FUNDS 

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—100.0% (CONT.)   SHARES     VALUE  
PHARMACEUTICALS—1.6%            
AstraZeneca PLC#     194,803     $ 13,967,375  
Eli Lilly & Co.     24,808       11,276,476  
Reata Pharmaceuticals, Inc., Cl. A*     49,844       8,253,170  
              33,497,021  
SEMICONDUCTORS—13.2%            
Advanced Micro Devices, Inc.*     143,114       16,372,242  
Broadcom, Inc.     4,703       4,226,351  
First Solar, Inc.*     51,462       10,673,219  
Marvell Technology, Inc.     617,287       40,203,902  
NVIDIA Corp.     369,643       172,730,477  
ON Semiconductor Corp.*     96,205       10,366,089  
Taiwan Semiconductor Manufacturing Co., Ltd.#     278,571       27,620,315  
              282,192,595  
SPECIALTY CHEMICALS—0.9%            
Albemarle Corp.     86,207       18,300,022  
SYSTEMS SOFTWARE—14.9%            
Microsoft Corp.     835,512       280,665,191  
Oracle Corp.     151,613       17,773,592  
Palo Alto Networks, Inc.*     6,037       1,509,009  
ServiceNow, Inc.*     34,249       19,967,167  
              319,914,959  
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.5%            
Apple, Inc.     820,289       161,145,774  
TRANSACTION & PAYMENT PROCESSING SERVICES—3.7%            
Toast, Inc., Cl. A*     487,088       10,750,032  
Visa, Inc., Cl. A     287,306       68,301,256  
              79,051,288  
TOTAL COMMON STOCKS                
(Cost $1,158,486,654)             2,143,767,766  

 

PREFERRED STOCKS—0.1%     SHARES       VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—0.1%            
Chime Financial, Inc., Series G*,@,(a)     38,919       1,670,014  
(Cost $2,688,128)             1,670,014  

 

SPECIAL PURPOSE VEHICLE—0.1%             VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—0.1%            
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             3,203,289  
(Cost $3,075,000)             3,203,289  
Total Investments                
(Cost $1,164,249,782)     100.2 %   $ 2,148,641,069  
Affiliated Securities (Cost $3,075,000)             3,203,289  
Unaffiliated Securities (Cost $1,161,174,782)             2,145,437,780  
Liabilities in Excess of Other Assets     (0.2 )%     (4,892,904 )
NET ASSETS     100.0 %   $ 2,143,748,165  

 

# American Depositary Receipts.

 

- 4 -

THE ALGER INSTITUTIONAL FUNDS 

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).

(b) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.

* Non-income producing security.

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Chime Financial, Inc., Series G   8/24/21   $ 2,688,128       0.06%     $ 1,670,014       0.08 %
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20     3,075,000       0.08%       3,203,289       0.15 %
Total                       $ 4,873,303       0.23 %

 

See Notes to Financial Statements.

 

- 5 -

THE ALGER INSTITUTIONAL FUNDS │ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—99.4%   SHARES     VALUE  
ADVERTISING—0.9%              
The Trade Desk, Inc., Cl. A*     126,173      $ 11,514,548  
AEROSPACE & DEFENSE—2.6%              
TransDigm Group, Inc.     37,807       34,015,714  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%              
LVMH Moet Hennessy Louis Vuitton SE     7,317       6,795,795  
APPLICATION SOFTWARE—4.5%              
Adobe, Inc.*     47,332       25,851,318  
Datadog, Inc., Cl. A*     123,736       14,442,466  
Intuit, Inc.     22,621       11,575,166  
Salesforce, Inc.*     35,099       7,897,626  
              59,766,576  
AUTOMOBILE MANUFACTURERS—1.7%              
Tesla, Inc.*     83,944       22,449,144  
AUTOMOTIVE PARTS & EQUIPMENT—0.8%              
Mobileye Global, Inc., Cl. A*     277,214       10,584,030  
BIOTECHNOLOGY—2.2%              
Natera, Inc.*     382,877       17,313,698  
Vaxcyte, Inc.*     260,149       12,502,761  
              29,816,459  
BROADLINE RETAIL—7.3%              
Amazon.com, Inc.*     545,373       72,905,463  
MercadoLibre, Inc.*     19,520       24,166,736  
              97,072,199  
CASINOS & GAMING—3.6%              
DraftKings, Inc., Cl. A*     356,748       11,337,451  
Flutter Entertainment PLC*     128,555       25,569,531  
MGM Resorts International     220,569       11,198,288  
              48,105,270  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—1.0%              
Wabtec Corp.     108,659       12,869,572  
CONSTRUCTION MATERIALS—2.0%              
Martin Marietta Materials, Inc.     60,418       26,974,220  
DIVERSIFIED BANKS—1.1%              
JPMorgan Chase & Co.     89,317       14,108,513  
ELECTRICAL COMPONENTS & EQUIPMENT—1.0%              
Eaton Corp. PLC     24,120       4,952,318  
Vertiv Holdings Co., Cl. A     306,054       7,960,465  
              12,912,783  
ENVIRONMENTAL & FACILITIES SERVICES—2.6%              
GFL Environmental, Inc.     1,009,628       34,468,700  
FINANCIAL EXCHANGES & DATA—2.8%              
CME Group, Inc., Cl. A     68,699       13,668,353  
S&P Global, Inc.     58,551       23,098,955  
              36,767,308  
HEALTHCARE DISTRIBUTORS—1.0%              
McKesson Corp.     34,187       13,756,849  

 

- 6 - 

THE ALGER INSTITUTIONAL FUNDS│ ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—99.4% (CONT.)   SHARES     VALUE  
HEALTHCARE EQUIPMENT—4.1%            
Boston Scientific Corp.*     301,316     $ 15,623,235  
GE HealthCare Technologies, Inc.     82,197       6,411,366  
TransMedics Group, Inc.*     343,041       31,964,560  
              53,999,161  
HEALTHCARE FACILITIES—1.0%            
Acadia Healthcare Co., Inc.*     174,820       13,816,025  
HOTELS RESORTS & CRUISE LINES—1.3%            
Trip.com Group Ltd.#,*     423,257       17,370,467  
INDUSTRIAL GASES—0.8%            
Air Products & Chemicals, Inc.     37,125       11,335,376  
INTERACTIVE MEDIA & SERVICES—9.2%            
Alphabet, Inc., Cl. C*     449,291       59,805,125  
Meta Platforms, Inc., Cl. A*     196,833       62,710,994  
              122,516,119  
LIFE SCIENCES TOOLS & SERVICES—0.9%            
Danaher Corp.     45,206       11,530,242  
MANAGED HEALTHCARE—1.8%            
UnitedHealth Group, Inc.     46,539       23,565,953  
MOVIES & ENTERTAINMENT—3.1%            
Liberty Media Corp. Series C Liberty Formula One*     271,711       19,726,219  
Netflix, Inc.*     48,982       21,501,628  
              41,227,847  
OIL & GAS EQUIPMENT & SERVICES—1.2%            
Schlumberger NV     269,837       15,742,291  
OIL & GAS EXPLORATION & PRODUCTION—2.6%            
EOG Resources, Inc.     263,105       34,869,306  
PHARMACEUTICALS—0.9%            
AstraZeneca PLC#     170,078       12,194,593  
SEMICONDUCTORS—13.1%            
Advanced Micro Devices, Inc.*     87,988       10,065,827  
First Solar, Inc.*     36,331       7,535,049  
Marvell Technology, Inc.     429,874       27,997,694  
NVIDIA Corp.     224,233       104,781,839  
ON Semiconductor Corp.*     76,309       8,222,295  
Taiwan Semiconductor Manufacturing Co., Ltd.#     159,002       15,765,048  
              174,367,752  
SYSTEMS SOFTWARE—13.3%            
Microsoft Corp.     485,324       163,030,038  
ServiceNow, Inc.*     23,270       13,566,410  
              176,596,448  
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.9%            
Apple, Inc.     464,699       91,290,118  
TRANSACTION & PAYMENT PROCESSING SERVICES—3.6%            
Visa, Inc., Cl. A     202,234       48,077,089  
TOTAL COMMON STOCKS                
(Cost $899,202,246)           1,320,476,467  

- 7 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

PREFERRED STOCKS—0.0%   SHARES     VALUE  
BIOTECHNOLOGY—0.0%            
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     76,825     $ —    
(Cost $345,713)             —    
Total Investments                
(Cost $899,547,959)     99.4 %   $ 1,320,476,467  
Affiliated Securities (Cost $345,713)             —    
Unaffiliated Securities (Cost $899,202,246)             1,320,476,467  
Other Assets in Excess of Liabilities     0.6 %     8,525,341  
NET ASSETS     100.0 %   $ 1,329,001,808  

 

# American Depositary Receipts.
(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Prosetta Biosciences, Inc., Series D   2/6/15   $ 345,713       0.80%     $ 0       0.00 %
Total                       $ 0       0.00 %

 

See Notes to Financial Statements.

 

- 8 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—97.4%   SHARES     VALUE  
ADVERTISING—2.6%            
The Trade Desk, Inc., Cl. A*     18,176     $ 1,658,742  
AEROSPACE & DEFENSE—4.6%            
HEICO Corp.     7,999       1,407,664  
TransDigm Group, Inc.     1,725       1,552,017  
              2,959,681  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%            
Lululemon Athletica, Inc.*     772       292,225  
APPLICATION SOFTWARE—11.8%            
Bill.com Holdings, Inc.*     3,656       458,243  
Cadence Design Systems, Inc.*     4,120       964,121  
Constellation Software, Inc.     638       1,347,722  
Datadog, Inc., Cl. A*     11,813       1,378,813  
Guidewire Software, Inc.*     11,973       1,015,550  
Manhattan Associates, Inc.*     4,759       907,161  
Procore Technologies, Inc.*     7,251       549,988  
The Descartes Systems Group, Inc.*     11,763       917,333  
              7,538,931  
ASSET MANAGEMENT & CUSTODY BANKS—1.6%            
Ares Management Corp., Cl. A     10,620       1,053,716  
AUTOMOTIVE PARTS & EQUIPMENT—0.8%            
Mobileye Global, Inc., Cl. A*     13,413       512,108  
AUTOMOTIVE RETAIL—1.6%            
AutoZone, Inc.*     402       997,651  
BIOTECHNOLOGY—3.1%            
Apellis Pharmaceuticals, Inc.*     1,646       42,385  
Celldex Therapeutics, Inc.*     9,919       350,736  
Natera, Inc.*     26,710       1,207,826  
Vaxcyte, Inc.*     8,233       395,678  
              1,996,625  
BUILDING PRODUCTS—0.7%            
Trex Co., Inc.*     6,758       467,248  
CARGO GROUND TRANSPORTATION—2.2%            
Old Dominion Freight Line, Inc.     3,383       1,419,135  
CONSTRUCTION & ENGINEERING—1.6%            
WillScot Mobile Mini Holdings Corp.*     20,857       1,000,093  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—1.5%              
Wabtec Corp.     8,278       980,446  
CONSTRUCTION MATERIALS—2.2%            
Martin Marietta Materials, Inc.     3,085       1,377,329  
CONSUMER STAPLES MERCHANDISE RETAIL—0.8%            
BJ’s Wholesale Club Holdings, Inc.*     7,985       529,485  
ELECTRONIC COMPONENTS—2.0%            
Amphenol Corp., Cl. A     14,128       1,247,644  
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.5%            
Novanta, Inc.*     5,536       979,318  
ENVIRONMENTAL & FACILITIES SERVICES—3.3%            
GFL Environmental, Inc.     61,325       2,093,636  

 

- 9 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—97.4% (CONT.)   SHARES   VALUE
FINANCIAL EXCHANGES & DATA—2.5%            
MSCI, Inc., Cl. A     2,953     $ 1,618,480  
HEALTHCARE EQUIPMENT—6.9%            
Dexcom, Inc.*     9,974       1,242,362  
IDEXX Laboratories, Inc.*     2,784       1,544,368  
Insulet Corp.*     2,977       823,885  
Teleflex, Inc.     3,143       789,427  
              4,400,042  
HEALTHCARE FACILITIES—1.7%            
Acadia Healthcare Co., Inc.*     13,964       1,103,575  
HEALTHCARE TECHNOLOGY—1.7%            
Veeva Systems, Inc., Cl. A*     5,311       1,084,612  
HOME IMPROVEMENT RETAIL—2.0%            
Floor & Decor Holdings, Inc., Cl. A*     10,940       1,256,459  
HOMEBUILDING—1.8%            
NVR, Inc.*     186       1,172,998  
HOTELS RESORTS & CRUISE LINES—1.8%            
Hilton Worldwide Holdings, Inc.     7,364       1,145,028  
HUMAN RESOURCE & EMPLOYMENT SERVICES—1.8%            
Paycom Software, Inc.     3,180       1,172,657  
INSURANCE BROKERS—0.9%            
Ryan Specialty Holdings, Inc., Cl. A*     13,751       595,968  
INTERACTIVE MEDIA & SERVICES—0.7%            
Pinterest, Inc., Cl. A*     16,452       476,944  
INTERNET SERVICES & INFRASTRUCTURE—2.2%            
MongoDB, Inc., Cl. A*     3,357       1,421,354  
IT CONSULTING & OTHER SERVICES—1.5%            
Globant SA*     5,425       947,910  
LIFE SCIENCES TOOLS & SERVICES—5.8%            
Mettler-Toledo International, Inc.*     644       809,811  
Repligen Corp.*     7,401       1,269,715  
West Pharmaceutical Services, Inc.     4,492       1,653,236  
              3,732,762  
METAL, GLASS & PLASTIC CONTAINERS—0.7%            
Ball Corp.     7,629       447,746  
MOVIES & ENTERTAINMENT—1.8%            
Liberty Media Corp. Series C Liberty Formula One*     13,737       997,306  
Live Nation Entertainment, Inc.*     1,705       149,614  
              1,146,920  
OIL & GAS EXPLORATION & PRODUCTION—2.7%            
Diamondback Energy, Inc.     11,953       1,760,916  
OTHER SPECIALTY RETAIL—0.5%            
Five Below, Inc.*     1,534       319,594  
PROPERTY & CASUALTY INSURANCE—1.4%            
Intact Financial Corp.     5,888       869,728  
REAL ESTATE SERVICES—4.8%            
CoStar Group, Inc.*     12,810       1,075,656  
FirstService Corp.     12,878       2,017,081  
              3,092,737  

- 10 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—97.4% (CONT.)   SHARES   VALUE
RESEARCH & CONSULTING SERVICES—2.8%            
TransUnion     9,847     $ 784,707  
Verisk Analytics, Inc., Cl. A     4,391       1,005,276  
              1,789,983  
RESTAURANTS—3.2%            
Chipotle Mexican Grill, Inc., Cl. A*     499       979,178  
Domino’s Pizza, Inc.     2,750       1,091,035  
              2,070,213  
SEMICONDUCTOR MATERIALS & EQUIPMENT—0.5%            
KLA Corp.     641       329,442  
SEMICONDUCTORS—5.3%            
Lattice Semiconductor Corp.*     6,103       555,007  
Marvell Technology, Inc.     23,443       1,526,843  
ON Semiconductor Corp.*     12,434       1,339,764  
              3,421,614  
TOTAL COMMON STOCKS                
(Cost $52,480,521)             62,481,695  
                 
PREFERRED STOCKS—0.0%     SHARES       VALUE  
BIOTECHNOLOGY—0.0%            
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     166,009       —    
(Cost $747,040)             —    
                 
RIGHTS—0.5%     SHARES       VALUE  
BIOTECHNOLOGY—0.5%            
Tolero CDR*,@,(b),(c)     422,928       291,820  
(Cost $226,186)             291,820  
                 
SPECIAL PURPOSE VEHICLE—1.3%             VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—1.3%            
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             572,946  
Crosslink Ventures Capital C, LLC, Cl. B*,@,(a),(b)             235,764  
              808,710  
TOTAL SPECIAL PURPOSE VEHICLE                
(Cost $775,000)             808,710  
Total Investments                
(Cost $54,228,747)     99.2 %   $ 63,582,225  
Affiliated Securities (Cost $1,522,040)             808,710  
Unaffiliated Securities (Cost $52,706,707)             62,773,515  
Other Assets in Excess of Liabilities     0.8 %     484,125  
NET ASSETS     100.0 %   $ 64,066,350  

 

(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.

(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).

(c) Contingent Deferred Rights.

* Non-income producing security.

- 11 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20   $ 550,000       0.50%     $ 572,946       0.89 %
Crosslink Ventures Capital C, LLC, Cl. B   12/16/20     225,000       0.19%       235,764       0.37 %
Prosetta Biosciences, Inc., Series D   2/6/15     747,040       0.50%       0       0.00 %
Tolero CDR   2/6/17     226,186       0.23%       291,820       0.46 %
Total                       $ 1,100,530       1.72 %

 

See Notes to Financial Statements.

- 12 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—92.4%   SHARES     VALUE  
ADVERTISING—0.6%                
Magnite, Inc.*     58,652     $ 887,405  
AEROSPACE & DEFENSE—4.4%                
HEICO Corp.     22,096       3,888,454  
Hexcel Corp.     10,920       771,826  
Mercury Systems, Inc.*     38,152       1,449,013  
              6,109,293  
APPAREL ACCESSORIES & LUXURY GOODS—1.1%                
Capri Holdings Ltd.*     41,136       1,518,330  
APPAREL RETAIL—0.5%                
Aritzia, Inc.*     10,957       208,448  
Victoria’s Secret & Co.*     21,552       441,600  
              650,048  
APPLICATION SOFTWARE—24.0%                
ACI Worldwide, Inc.*     62,376       1,446,500  
AppFolio, Inc., Cl. A*     10,548       1,904,863  
Bill.com Holdings, Inc.*     19,264       2,414,550  
Blackbaud, Inc.*     21,038       1,587,317  
Blackline, Inc.*     29,917       1,737,579  
Everbridge, Inc.*     42,067       1,297,346  
Guidewire Software, Inc.*     17,034       1,444,824  
HubSpot, Inc.*     6,842       3,972,123  
Manhattan Associates, Inc.*     27,197       5,184,292  
Q2 Holdings, Inc.*     48,569       1,722,743  
SEMrush Holdings, Inc., Cl. A*     41,737       442,830  
Smartsheet, Inc., Cl. A*     31,943       1,418,269  
Sprout Social, Inc., Cl. A*     30,878       1,764,369  
SPS Commerce, Inc.*     29,903       5,394,202  
Vertex, Inc., Cl. A*     82,416       1,710,956  
              33,442,763  
ASSET MANAGEMENT & CUSTODY BANKS—0.4%                
Affiliated Managers Group, Inc.     4,469       619,582  
AUTOMOTIVE PARTS & EQUIPMENT—0.0%                
Atmus Filtration Technologies, Inc.*     1,847       44,051  
BIOTECHNOLOGY—6.6%                
ACELYRIN, Inc.*     11,317       281,114  
ADMA Biologics, Inc.*     208,870       866,810  
Alkermes PLC*     16,590       485,755  
Arcus Biosciences, Inc.*     17,175       341,783  
Avidity Biosciences, Inc.*     29,546       280,982  
Cabaletta Bio, Inc.*     114,375       1,557,788  
Celldex Therapeutics, Inc.*     21,328       754,158  
Karuna Therapeutics, Inc.*     5,952       1,189,031  
MoonLake Immunotherapeutics, Cl. A*     22,403       1,362,326  
Morphic Holding, Inc.*     14,724       835,293  
RAPT Therapeutics, Inc.*     30,555       730,265  
Vaxcyte, Inc.*     10,523       505,735  
              9,191,040  
- 13 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
CONSUMER STAPLES MERCHANDISE RETAIL—2.4%                
BJ’s Wholesale Club Holdings, Inc.*     50,157     $ 3,325,911  
DIVERSIFIED SUPPORT SERVICES—0.5%                
RB Global, Inc.     9,766       629,712  
ELECTRICAL COMPONENTS & EQUIPMENT—0.4%                
Sunrun, Inc.*     32,054       608,385  
ELECTRONIC EQUIPMENT & INSTRUMENTS—0.9%                
908 Devices, Inc.*     187,978       1,308,327  
FOOD DISTRIBUTORS—3.2%                
The Chefs’ Warehouse, Inc.*     40,013       1,454,072  
US Foods Holding Corp.*     68,800       2,939,824  
              4,393,896  
FOOTWEAR—0.6%                
On Holding AG, Cl. A*     22,379       805,644  
HEALTHCARE DISTRIBUTORS—0.3%                
PetIQ, Inc., Cl. A*     25,789       431,708  
HEALTHCARE EQUIPMENT—8.2%                
Impulse Dynamics PLC, Class E*,@,(a)     532,406       1,756,940  
Inmode Ltd.*     37,353       1,602,817  
Insulet Corp.*     10,926       3,023,771  
Paragon 28, Inc.*     30,114       532,114  
QuidelOrtho Corp.*     32,314       2,822,951  
Shockwave Medical, Inc.*     2,483       647,070  
Tandem Diabetes Care, Inc.*     30,237       1,055,876  
              11,441,539  
HEALTHCARE SERVICES—0.4%                
Privia Health Group, Inc.*     20,072       560,410  
HEALTHCARE SUPPLIES—1.0%                
Neogen Corp.*     61,064       1,416,074  
HEALTHCARE TECHNOLOGY—1.9%                
Doximity, Inc., Cl. A*     7,724       275,979  
Veeva Systems, Inc., Cl. A*     11,492       2,346,896  
              2,622,875  
HOMEBUILDING—0.5%                
Skyline Champion Corp.*     9,683       674,518  
HUMAN RESOURCE & EMPLOYMENT SERVICES—0.7%                
Paycom Software, Inc.     2,624       967,626  
INDUSTRIAL MACHINERY & SUPPLIES & COMPONENTS—0.7%                
Gates Industrial Corp., PLC*     68,151       928,217  
INTERACTIVE HOME ENTERTAINMENT—1.6%                
Take-Two Interactive Software, Inc.*     14,524       2,221,301  
INTERACTIVE MEDIA & SERVICES—0.8%                
Bumble, Inc., Cl. A*     28,543       528,617  
Tripadvisor, Inc.*     33,825       630,836  
              1,159,453  
LEISURE FACILITIES—1.0%                
Planet Fitness, Inc., Cl. A*     21,217       1,432,996  
- 14 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
LIFE SCIENCES TOOLS & SERVICES—7.6%                
Akoya Biosciences, Inc.*     60,048     $ 414,331  
Bio-Techne Corp.     51,271       4,276,001  
CryoPort, Inc.*     51,379       825,661  
ICON PLC*     7,793       1,959,238  
MaxCyte, Inc.*     80,083       357,971  
Mesa Laboratories, Inc.     3,769       484,920  
NanoString Technologies, Inc.*     63,851       303,931  
Personalis, Inc.*     126,736       299,097  
Repligen Corp.*     9,649       1,655,382  
              10,576,532  
MANAGED HEALTHCARE—1.8%                
HealthEquity, Inc.*     37,533       2,549,992  
MOVIES & ENTERTAINMENT—1.8%                
Live Nation Entertainment, Inc.*     29,285       2,569,759  
OIL & GAS EQUIPMENT & SERVICES—1.3%                
ChampionX Corp.     32,871       1,170,208  
ProPetro Holding Corp.*     67,383       703,478  
              1,873,686  
OIL & GAS EXPLORATION & PRODUCTION—3.3%                
Coterra Energy, Inc.     34,770       957,566  
Magnolia Oil & Gas Corp., Cl. A     162,878       3,607,747  
              4,565,313  
PERSONAL CARE PRODUCTS—0.5%                
Oddity Tech Ltd., Cl. A*     13,730       731,672  
PHARMACEUTICALS—1.4%                
Pliant Therapeutics, Inc.*     22,329       398,349  
Reata Pharmaceuticals, Inc., Cl. A*     6,984       1,156,411  
Ventyx Biosciences, Inc.*     10,465       387,728  
              1,942,488  
REGIONAL BANKS—0.9%                
Webster Financial Corp.     27,785       1,314,786  
RESEARCH & CONSULTING SERVICES—0.7%                
LegalZoom.com, Inc.*     60,985       931,851  
RESTAURANTS—6.6%                
Cava Group, Inc.*     5,545       316,675  
Kura Sushi USA, Inc., Cl. A*     21,124       2,102,049  
Shake Shack, Inc., Cl. A*     29,210       2,268,448  
The Cheesecake Factory, Inc.     33,851       1,245,040  
Wingstop, Inc.     19,374       3,266,069  
              9,198,281  
SEMICONDUCTOR MATERIALS & EQUIPMENT—0.8%                
SolarEdge Technologies, Inc.*     4,446       1,073,531  
SEMICONDUCTORS—0.7%                
Universal Display Corp.     6,648       969,810  
SPECIALTY CHEMICALS—0.3%                
Balchem Corp.     2,834       381,853  
SYSTEMS SOFTWARE—0.4%                
Rapid7, Inc.*     11,833       543,253  
- 15 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
TRADING COMPANIES & DISTRIBUTORS—0.4%                
Xometry, Inc., Cl. A*     27,198     $ 564,630  
TRANSACTION & PAYMENT PROCESSING SERVICES—1.2%                
DLocal Ltd., Cl. A*     70,819       1,074,324  
Marqeta, Inc., Cl. A*     115,506       644,524  
              1,718,848  
TOTAL COMMON STOCKS                
(Cost $96,188,422)             128,897,389  

 

PREFERRED STOCKS—3.5%   SHARES       VALUE
BIOTECHNOLOGY—0.0%                
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     133,263        
DATA PROCESSING & OUTSOURCED SERVICES—3.5%                
Chime Financial, Inc., Series G*,@,(a)     114,399       4,908,861  
TOTAL PREFERRED STOCKS             4,908,861  
(Cost $8,501,200)                

 

RIGHTS—0.3%   SHARES     VALUE  
BIOTECHNOLOGY—0.3%                
Tolero CDR*,@,(a),(c)     528,559       364,706  
(Cost $285,725)             364,706  

 

REAL ESTATE INVESTMENT TRUST—1.8%   SHARES     VALUE  
RETAIL—1.8%                
Tanger Factory Outlet Centers, Inc.     110,050       2,576,270  
(Cost $1,810,916)             2,576,270  

 

SPECIAL PURPOSE VEHICLE—1.2%           VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—1.2%                
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             1,328,193  
Crosslink Ventures Capital C, LLC, Cl. B*,@,(a),(b)             340,548  
              1,668,741  
TOTAL SPECIAL PURPOSE VEHICLE             1,668,741  
(Cost $1,600,000)                
Total Investments                
(Cost $108,386,263)     99.2 %   $ 138,415,967  
Affiliated Securities (Cost $2,199,684)             1,668,741  
Unaffiliated Securities (Cost $106,186,579)             136,747,226  
Other Assets in Excess of Liabilities     0.8 %     1,101,587  
NET ASSETS     100.0 %   $ 139,517,554  

 

(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).
(b) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.
(c) Contingent Deferred Rights.
* Non-income producing security.
- 16 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Chime Financial, Inc., Series G   8/24/21   $ 7,901,516       2.12%     $ 4,908,861       3.52 %
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20     1,275,000       0.49%       1,328,193       0.95 %
Crosslink Ventures Capital C, LLC, Cl. B   12/16/20     325,000       0.11%       340,548       0.25 %
Impulse Dynamics PLC, Class E   2/11/22     1,756,940       0.71%       1,756,940       1.26 %
Prosetta Biosciences, Inc., Series D   2/6/15     599,684       0.10%       0       0.00 %
Tolero CDR   2/6/17     285,725       0.16%       364,706       0.26 %
Total                       $ 8,699,248       6.24 %

 

See Notes to Financial Statements.

 

- 17 - 

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited)

 

 

NOTE 1 — General:

 

The Alger Institutional Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 946 – Financial Services – Investment Companies. The Trust operates as a series company currently offering an unlimited number of shares of beneficial interest in four series – Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund (collectively, the “Funds” or individually, each a “Fund”). The Funds normally invest primarily in equity securities and each has an investment objective of long-term capital appreciation.

 

Each Fund offers one or more of the following share classes: Class A, C, I, R, Y, Z and Z-2. Class A shares are generally subject to an initial sales charge while Class C shares are generally subject to a deferred sales charge. Class I, R, Y, Z and Z-2 shares are generally sold to institutional investors and are sold without an initial or deferred sales charge and Class Y, Z and Z-2 shares are generally subject to a minimum initial investment of $500,000. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the eighth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Effective August 27, 2019, Class C shares were closed to direct shareholders and are only available for purchase through certain financial intermediaries and group retirement plan recordkeeping platforms. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of the Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).

 

On May 23, 2023, the Board of Trustees (the “Board”) approved the transition of the Fund’s custodian and administrator from Brown Brothers Harriman & Company (the “Custodian”) to The Bank of New York Mellon. This change is anticipated to become effective in early 2024.

 

NOTE 2 — Significant Accounting Policies:

 

(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). Investments held by the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Time).

 

The Board has designated, pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended (the “1940 Act”), the Funds’ investment adviser, Fred Alger Management, LLC (“Alger Management” or the “Investment Manager”) as its valuation designee (the “Valuation Designee”) to make fair value determinations subject to the Board’s review and oversight. The Valuation Designee has established a Valuation Committee (“Committee”) comprised of representatives of the Investment Manager and officers of the Funds to assist in performing the duties and responsibilities of the Valuation Designee.

 

- 18 - 

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

The Valuation Designee has established valuation processes including but not limited to: (i) making fair value determinations when market quotations for financial instruments are not readily available in accordance with valuation policies and procedures adopted by the Board; (ii) assessing and managing material risks associated with fair valuation determinations; (iii) selecting, applying and testing fair valuation methodologies; and (iv) overseeing and evaluating pricing services used by the Funds. The Valuation Designee regularly reports its fair valuation determinations and related valuation information to the Board. The Committee generally meets quarterly and on an as-needed basis to review and evaluate the effectiveness of the valuation policies and procedures in accordance with the requirements of Rule 2a-5.

 

Investments in money market funds and short-term securities held by the Funds having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.

 

Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are generally valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.

 

Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Valuation Designee, through its Committee, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the NYSE is open.

 

FASB Accounting Standards Codification 820 – Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.

 

- 19 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Level 1 – quoted prices in active markets for identical investments

 

Level 2 – significant other observable inputs (including quoted prices for similar investments, amortized cost, interest rates, prepayment speeds, credit risk, etc.)

 

Level 3 – significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)

 

The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Funds may significantly differ from the valuations that would have been assigned by the Funds had there been an active market for such securities.

 

(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash and overnight time deposits.

 

NOTE 3 — Fair Value Measurements:

 

The following is a summary of the inputs used as of July 31, 2023 in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.

 

- 20 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

  

Alger Capital Appreciation                
Institutional Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services   $ 266,720,041     $ 266,720,041     $     $  
Consumer Discretionary     345,924,823       334,878,057       11,046,766        
Energy     76,860,271       76,860,271              
Financials     145,611,402       145,611,402              
Healthcare     242,322,789       242,322,789              
Industrials     141,775,145       141,775,145              
Information Technology     865,174,841       865,174,841              
Materials     59,378,454       59,378,454              
TOTAL COMMON STOCKS   $ 2,143,767,766     $ 2,132,721,000     $ 11,046,766     $  
PREFERRED STOCKS                                
Information Technology     1,670,014                   1,670,014  
SPECIAL PURPOSE VEHICLE                                
Information Technology     3,203,289                   3,203,289  
TOTAL INVESTMENTS IN SECURITIES   $ 2,148,641,069     $ 2,132,721,000     $ 11,046,766     $ 4,873,303  

 

Alger Focus Equity Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services     175,258,514       175,258,514              
Consumer Discretionary     202,376,905       195,581,110       6,795,795        
Energy     50,611,597       50,611,597              
Financials     98,952,910       98,952,910              
Healthcare     158,679,282       158,679,282              
Industrials     94,266,769       94,266,769              
Information Technology     502,020,894       502,020,894              
Materials     38,309,596       38,309,596              
TOTAL COMMON STOCKS   $ 1,320,476,467     $ 1,313,680,672     $ 6,795,795     $  
PREFERRED STOCKS                                
Healthcare     *                 *
TOTAL INVESTMENTS IN SECURITIES   $ 1,320,476,467     $ 1,313,680,672     $ 6,795,795     $  

 

- 21 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Alger Mid Cap Growth Institutional                
Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services   $ 3,282,606     $ 3,282,606     $     $  
Consumer Discretionary     7,766,276       7,766,276              
Consumer Staples     529,485       529,485              
Energy     1,760,916       1,760,916              
Financials     4,137,892       4,137,892              
Healthcare     12,317,616       12,317,616              
Industrials     11,882,879       11,882,879              
Information Technology     15,886,213       15,886,213              
Materials     1,825,075       1,825,075              
Real Estate     3,092,737       3,092,737              
TOTAL COMMON STOCKS   $ 62,481,695     $ 62,481,695     $     $  
PREFERRED STOCKS                                
Healthcare     *                 *
RIGHTS                                
Healthcare     291,820                   291,820  
SPECIAL PURPOSE VEHICLE                                
Information Technology     808,710                   808,710  
TOTAL INVESTMENTS IN SECURITIES   $ 63,582,225     $ 62,481,695     $     $ 1,100,530  

 

Alger Small Cap Growth                                
Institutional Fund     TOTAL       LEVEL 1       LEVEL 2       LEVEL 3  
COMMON STOCKS                                
Communication Services     6,837,918       6,837,918              
Consumer Discretionary     14,323,868       14,323,868              
Consumer Staples     8,451,479       8,451,479              
Energy     6,438,999       6,438,999              
Financials     3,653,216       3,653,216              
Healthcare     40,732,658       38,975,718             1,756,940  
Industrials     10,739,714       10,739,714              
Information Technology     37,337,684       37,337,684              
Materials     381,853       381,853              
TOTAL COMMON STOCKS   $ 128,897,389     $ 127,140,449     $     $ 1,756,940  
PREFERRED STOCKS                                
Healthcare     *                 *
Information Technology     4,908,861                   4,908,861  
TOTAL PREFERRED STOCKS   $ 4,908,861     $     $     $ 4,908,861  
RIGHTS                                
Healthcare     364,706                   364,706  
REAL ESTATE INVESTMENT TRUST                                
Real Estate     2,576,270       2,576,270              
SPECIAL PURPOSE VEHICLE                                
Information Technology     1,668,741                   1,668,741  
TOTAL INVESTMENTS IN SECURITIES   $ 138,415,967     $ 129,716,719     $     $ 8,699,248  

 

* Alger Focus Equity Fund’s, Alger Mid Cap Growth Institutional Fund’s and Alger Small Cap Growth Institutional Fund’s holdings of Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

 

- 22 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Common Stocks  
Opening balance at November 1, 2022   $ 585,947  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments     (1,232,569 )
Included in net change in unrealized appreciation (depreciation) on investments     1,880,166  
Purchases and sales        
Purchases      
Sales     (1,233,544 )
Closing balance at July 31, 2023      
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ 1,699,204  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (29,190 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,670,014  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (29,190 )

 

- 23 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Special Purpose
Vehicle
 
Opening balance at November 1, 2022   $ 3,252,120  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (48,831 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     3,203,289  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (48,831 )

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Focus Equity Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

- 24 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund   Rights  
Opening balance at November 1, 2022   $ 253,757  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     38,063  
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     291,820  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ 38,063  

 

- 25 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3) 

 
    Special Purpose  
Alger Mid Cap Growth Institutional Fund   Vehicle  
Opening balance at November 1, 2022   $ 821,566  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (12,856 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     808,710  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (12,856 )

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3) 

 
Alger Small Cap Growth Institutional Fund   Common Stocks  
Opening balance at November 1, 2022   $ 1,756,940  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,756,940  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

- 26 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3)

 
Alger Small Cap Growth Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ 4,994,660 *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (85,799 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     4,908,861 *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (85,799 )

 

   

FAIR VALUE

MEASUREMENTS

USING SIGNIFICANT

UNOBSERVABLE

INPUTS (LEVEL 3)

 
Alger Small Cap Growth Institutional Fund   Rights
Opening balance at November 1, 2022   $ 317,135  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     47,571  
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     364,706  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ 47,571  

 

- 27 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund   Special Purpose Vehicle  
Opening balance at November 1, 2022   $ 1,694,942  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (26,201 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,668,741  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (26,201 )

 

* Includes securities that are fair valued at zero.

 

The following table provides quantitative information about each Fund’s Level 3 fair value measurements of its investments as of July 31, 2023. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to each Fund’s fair value measurements.

 

    Fair Value Valuation Unobservable   Weighted Average
    July 31, 2023 Methodology Input Input/Range Inputs
Alger Capital Appreciation Institutional Fund      
Preferred Stocks $ 1,670,014 Market Approach Revenue Multiple 14.0x-16.0x N/A
Special Purpose Vehicle   3,203,289 Market Approach Revenue Multiple 14.0x-16.0x N/A
             
Alger Focus Equity Fund      
Preferred Stocks   —* Income Approach Discount Rate 100.00% N/A
             
Alger Mid Cap Growth Institutional Fund      
Preferred Stocks   —* Income Approach Discount Rate 100.00% N/A
Rights   291,820 Income Approach Discount Rate
Probability of Success
7.94%-9.43%
0.00%-60.00%
N/A
Special Purpose Vehicle   808,710 Market Approach Revenue Multiple 14.0x-16.0x N/A

 

- 28 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

 

 

Fair Value

July 31, 2023

Valuation

Methodology

Unobservable

Input

Input/Range

Weighted Average

Inputs

Alger Small Cap Growth Institutional Fund          
Common Stocks $ 1,756,940 Market Approach Recent
Transaction Price
N/A N/A
Preferred Stocks   —* Income Approach Discount Rate 100.00 % N/A
Preferred Stocks   4,908,861 Market Approach Revenue Multiple 14.0x-16.0x N/A
Rights   364,706 Income Approach Discount Rate
Probability of Success
7.94%-9.43%
0.00%-60.00%
N/A
Special Purpose Vehicle   1,668,741 Market Approach Revenue Multiple 14.0x-16.0x N/A

 

* Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

 

The significant unobservable inputs used in the fair value measurement of each Fund’s securities are revenue and EBITDA multiples, discount rates, and the probability of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probability of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probability of success result in lower fair value measurements.

 

Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial reporting purposes. As of July 31, 2023, such assets were categorized within the ASC 820 disclosure hierarchy as follows:

 

    TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
Cash, foreign cash and cash equivalents                                
Alger Capital Appreciation Institutional Fund     $ 913,721     $ 47     $ 913,674     $  
Alger Focus Equity Fund     7,046,942             7,046,942        
Alger Mid Cap Growth Institutional Fund     1,010,738             1,010,738        
Alger Small Cap Growth Institutional Fund     276,716             276,716        

 

NOTE 4 — Affiliated Securities:

 

During the nine-month period ended July 31, 2023, as disclosed in the following table, certain Funds held 5% or more of the outstanding voting securities of the issuers listed below. As such, these issuers were “affiliated persons” of the applicable Fund(s) for purposes of the 1940 Act. Transactions during the nine-month period ended July 31, 2023 with such affiliated persons are summarized below. During this period, other Funds in the Trust may also have held voting shares of the issuers at levels below 5%.

 

- 29 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Security   Shares
Held at
October 31,
2022
  Shares
Purchased
  Shares
Sold
  Shares
Held at
July 31,
2023
    Dividend
Income
  Realized
Gain (Loss)
  Net Change
in
Unrealized
App(Dep)
  Value at
July 31,
2023
Alger Capital Appreciation Institutional Fund                                                  
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                   $     $     $ (48,831 )   $ 3,203,289  
Total                     $     $     $ (48,831 )   $ 3,203,289  

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
    Shares
Sold
    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Focus Equity Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     76,825                   76,825     $     $     $     $ *
Total                                   $     $     $     $ *

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
   

Shares

Sold

    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Mid Cap Growth Institutional Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     166,009                   166,009     $     $     $     $ *
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                                 (8,734 )     572,946  
Crosslink Ventures Capital C, LLC, Cl. B***                                                 (4,122 )     235,764  
Total                                   $     $     $ (12,856 )   $ 808,710  

 

- 30 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
    Shares
Sold
    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Small Cap Growth Institutional Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     133,263                   133,263     $     $     $     $ *
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                                 (20,247 )     1,328,193  
Crosslink Ventures Capital C, LLC, Cl. B***                                                 (5,954 )     340,548  
Total                                   $     $     $ (26,201 )   $ 1,668,741  

 

* Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

** Prosetta Biosciences, Inc., Series D is deemed to be an affiliate of the Funds because the Funds and Prosetta Biosciences, Inc., Series D are under common control.

*** The Alger Fund Complex and other entities managed by Alger Management fully own Crosslink Ventures Capital C, LLC, Class A and Crosslink Ventures Capital C, LLC, Class B. There were no capital increases or decreases for the period ended July 31, 2023.

 

- 31 -